Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

These patients were compared to a control group of 206,005 with no history of Ozempic use. The cohorts were analyzed to determine the relationship between the time elapsed from their last Ozempic ...

The EMA’s safety committee has said that, after a review of available data, it has found no evidence that GLP-1 agonist drugs such ... in people with a family history of thyroid cancer.

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing disordered eating.

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Partnership is expected to support Phase III development of VK2735 in patients with obesity and metabolic disorders amid ...

"Concerns arise over GLP-1 use during major surgeries like joint replacements. A study reveals optimal timing for stopping Ozempic to reduce anesthesia risks." ...

GLP-1RAs were not associated with an increased risk for thyroid cancer relative to DPP-4 inhibitor use among an international cohort.

A real-world study of over 4,000 US patients without type 2 diabetes found that those who persisted with Tirzepatide for at ...